164 related articles for article (PubMed ID: 33621446)
1. A systematic review of pharmacologic therapies for the cardiomyopathy of Duchenne muscular dystrophy.
Kipke J; Birnkrant DJ; Jin JB; Aneja A; Bahler RC
Pediatr Pulmonol; 2021 Apr; 56(4):782-795. PubMed ID: 33621446
[TBL] [Abstract][Full Text] [Related]
2. Effects of angiotensin-converting enzyme inhibitors and/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy.
Viollet L; Thrush PT; Flanigan KM; Mendell JR; Allen HD
Am J Cardiol; 2012 Jul; 110(1):98-102. PubMed ID: 22463839
[TBL] [Abstract][Full Text] [Related]
3. Randomised placebo-controlled trial of combination ACE inhibitor and beta-blocker therapy to prevent cardiomyopathy in children with Duchenne muscular dystrophy? (DMD Heart Protection Study): a protocol study.
Bourke JP; Watson G; Muntoni F; Spinty S; Roper H; Guglieri M; Speed C; McColl E; Chikermane A; Jayawant S; Adwani S; Willis T; Wilkinson J; Bryant A; Chadwick T; Wood R; Bushby K;
BMJ Open; 2018 Dec; 8(12):e022572. PubMed ID: 30573480
[TBL] [Abstract][Full Text] [Related]
4. Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial.
Dittrich S; Graf E; Trollmann R; Neudorf U; Schara U; Heilmann A; von der Hagen M; Stiller B; Kirschner J; Pozza RD; Müller-Felber W; Weiss K; von Au K; Khalil M; Motz R; Korenke C; Lange M; Wilichowski E; Pattathu J; Ebinger F; Wiechmann N; Schröder R;
Orphanet J Rare Dis; 2019 May; 14(1):105. PubMed ID: 31077250
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy.
Ogata H; Ishikawa Y; Ishikawa Y; Minami R
J Cardiol; 2009 Feb; 53(1):72-8. PubMed ID: 19167641
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies.
Mavrogeni SI; Markousis-Mavrogenis G; Papavasiliou A; Papadopoulos G; Kolovou G
Methods Mol Biol; 2018; 1687():31-42. PubMed ID: 29067654
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological therapy for the prevention and management of cardiomyopathy in Duchenne muscular dystrophy: A systematic review.
El-Aloul B; Altamirano-Diaz L; Zapata-Aldana E; Rodrigues R; Malvankar-Mehta MS; Nguyen CT; Campbell C
Neuromuscul Disord; 2017 Jan; 27(1):4-14. PubMed ID: 27815032
[TBL] [Abstract][Full Text] [Related]
8. Progressive left ventricular dysfunction and myocardial fibrosis in Duchenne and Becker muscular dystrophy: a longitudinal cardiovascular magnetic resonance study.
Aikawa T; Takeda A; Oyama-Manabe N; Naya M; Yamazawa H; Koyanagawa K; Ito YM; Anzai T
Pediatr Cardiol; 2019 Feb; 40(2):384-392. PubMed ID: 30564867
[TBL] [Abstract][Full Text] [Related]
9. Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy: A Randomized Clinical Trial.
Silva MC; Magalhães TA; Meira ZM; Rassi CH; Andrade AC; Gutierrez PS; Azevedo CF; Gurgel-Giannetti J; Vainzof M; Zatz M; Kalil-Filho R; Rochitte CE
JAMA Cardiol; 2017 Feb; 2(2):190-199. PubMed ID: 27926769
[TBL] [Abstract][Full Text] [Related]
10. Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance.
Hor KN; Mazur W; Taylor MD; Al-Khalidi HR; Cripe LH; Jefferies JL; Raman SV; Chung ES; Kinnett KJ; Williams K; Gottliebson WM; Benson DW
J Cardiovasc Magn Reson; 2011 Oct; 13(1):60. PubMed ID: 22011358
[TBL] [Abstract][Full Text] [Related]
11. Beta-blockers in Children with Duchenne Cardiomyopathy.
Matsumura T
Rev Recent Clin Trials; 2014; 9(2):76-81. PubMed ID: 25198739
[TBL] [Abstract][Full Text] [Related]
12. Effects of cardiac medications on ventricular function in patients with Duchenne muscular dystrophy-related cardiomyopathy.
Murphy AP; Johnson A; Straub V; Heads-Baister A; Lord S; Bourke JP
Muscle Nerve; 2021 Aug; 64(2):163-171. PubMed ID: 34050938
[TBL] [Abstract][Full Text] [Related]
13. Response of doxorubicin-induced cardiomyopathy to the current management strategy of heart failure.
Tallaj JA; Franco V; Rayburn BK; Pinderski L; Benza RL; Pamboukian S; Foley B; Bourge RC
J Heart Lung Transplant; 2005 Dec; 24(12):2196-201. PubMed ID: 16364871
[TBL] [Abstract][Full Text] [Related]
14. Left Ventricular Tonic Contraction as a Novel Biomarker of Cardiomyopathy in Duchenne Muscular Dystrophy.
Su JA; Ramos-Platt L; Menteer J
Pediatr Cardiol; 2016 Apr; 37(4):678-85. PubMed ID: 26714815
[TBL] [Abstract][Full Text] [Related]
15. Association between prophylactic angiotensin-converting enzyme inhibitors and overall survival in Duchenne muscular dystrophy-analysis of registry data.
Porcher R; Desguerre I; Amthor H; Chabrol B; Audic F; Rivier F; Isapof A; Tiffreau V; Campana-Salort E; Leturcq F; Tuffery-Giraud S; Ben Yaou R; Annane D; Amédro P; Barnerias C; Bécane HM; Béhin A; Bonnet D; Bassez G; Cossée M; de La Villéon G; Delcourte C; Fayssoil A; Fontaine B; Godart F; Guillaumont S; Jaillette E; Laforêt P; Leonard-Louis S; Lofaso F; Mayer M; Morales RJ; Meune C; Orlikowski D; Ovaert C; Prigent H; Saadi M; Sochala M; Tard C; Vaksmann G; Walther-Louvier U; Eymard B; Stojkovic T; Ravaud P; Duboc D; Wahbi K
Eur Heart J; 2021 May; 42(20):1976-1984. PubMed ID: 33748842
[TBL] [Abstract][Full Text] [Related]
16. Cardiac management of ventilator-assisted individuals with Duchenne muscular dystrophy.
O'Brien L; Varadi R; Goldstein RS; Evans RA
Chron Respir Dis; 2014 May; 11(2):103-10. PubMed ID: 24728656
[TBL] [Abstract][Full Text] [Related]
17. Effect of Prescribing Patterns of Renin-Angiotensin System Blockers and Beta-Blockers on Prognosis of Heart Failure.
Kim HJ; Jo SH; Lee MH; Seo WW; Choi JO; Ryu KH
Adv Ther; 2020 Sep; 37(9):3839-3849. PubMed ID: 32676928
[TBL] [Abstract][Full Text] [Related]
18. Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics.
Fayssoil A; Nardi O; Orlikowski D; Annane D
Heart Fail Rev; 2010 Jan; 15(1):103-7. PubMed ID: 19943106
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological management of dilated cardiomyopathy in Duchenne muscular dystrophy: A systematic review.
Haddad CN; Ali S; Stephanou D; Assakura MS; Sahagian L; Trogkanis E
Hellenic J Cardiol; 2023; 74():58-64. PubMed ID: 37406964
[TBL] [Abstract][Full Text] [Related]
20. Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy.
Finsterer J; Stöllberger C
Neuromuscul Disord; 2009 Jan; 19(1):74; author reply 75. PubMed ID: 19070488
[No Abstract] [Full Text] [Related]
[Next] [New Search]
